Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2026
Exchange summary
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2026
Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2026